Compound Detail
CHEMBL3414621
TAZEMETOSTAT 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
CCN(c1cc(-c2ccc(CN3CCOCC3)cc2)cc(C(=O)NCc2c(C)cc(C)[nH]c2=O)c1C)C1CCOCC1
Basic Information
| ChEMBL ID | CHEMBL3414621 |
| Name | TAZEMETOSTAT |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | NSQSAUGJQHDYNO-UHFFFAOYSA-N |
| Therapeutic | ✓ Yes |
25
Targets
103
Activities
4
Assay Types
30
PK Parameters
20
Publications
5
Known Names
13
Indications
Molecular Properties
572.8
MW (Da)
4.73
ALogP
6
HBA
2
HBD
86.9
PSA (Ų)
0.39
QED
1
Ro5 Violations
9
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 2020 |
| Availability | Prescription |
| Chirality | Achiral |
Indications
Neoplasms Lymphoma, Follicular Lymphoma, Follicular Sarcoma Lymphoma Mesothelioma Carcinoma, Non-Small-Cell Lung Carcinoma, Squamous Cell Leukemia, Myeloid, Acute Lymphoma, Large B-Cell, Diffuse Multiple Myeloma Prostatic Neoplasms Urinary Bladder Neoplasms
ATC Classification
L01XX72
tazemetostat
Level 1: ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
Level 2: ANTINEOPLASTIC AGENTS
Activity Summary
IC50 84 meas. best 9.47
EC50 10 meas. best 8.3
Ki 5 meas. best 8.6
Kd 4 meas. best 8.07
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Histone-lysine N-methyltransferase EZH2 CHEMBL2189110 | IC50 | 9.47 | 8.1958 | 0.3 | 36 |
| Unchecked CHEMBL612545 | IC50 | 9.43 | 7.5373 | 0.4 | 11 |
| Polycomb protein EED CHEMBL2189117 | IC50 | 8.7 | 8.05 | 2.0 | 2 |
| Pfeiffer CHEMBL4296489 | IC50 | 8.65 | 7.8467 | 2.3 | 3 |
| Unchecked CHEMBL612545 | Ki | 8.6 | 8.6 | 2.5 | 2 |
| Histone-lysine N-methyltransferase EZH2 CHEMBL2189110 | Ki | 8.6 | 8.6 | 2.5 | 3 |
| KARPAS-422 CHEMBL2366368 | IC50 | 8.41 | 7.58 | 3.9 | 4 |
| Histone-lysine N-methyltransferase EZH2 CHEMBL4739840 | IC50 | 8.4 | 8.4 | 4.0 | 1 |
| EZH1/SUZ12/EED/AEBP2/RBBP4 complex CHEMBL3137287 | IC50 | 8.4 | 8.4 | 4.0 | 1 |
| Histone-lysine N-methyltransferase EZH2 CHEMBL2189110 | EC50 | 8.3 | 7.348 | 5.0 | 10 |
| WSUDLCL2 CHEMBL5058628 | IC50 | 8.19 | 8.19 | 6.4 | 1 |
| Unchecked CHEMBL612545 | Kd | 8.07 | 7.98 | 8.6 | 3 |
| Histone-lysine N-methyltransferase EZH2 CHEMBL2189110 | Kd | 8.04 | 8.04 | 9.1 | 1 |
| Histone-lysine N-methyltransferase EZH1 CHEMBL2189116 | IC50 | 7.03 | 6.555 | 93.0 | 4 |
| Medulloblastoma cell CHEMBL4296520 | IC50 | 5.06 | 5.06 | 8740.0 | 1 |
| MDA-MB-231 CHEMBL400 | IC50 | 4.96 | 4.53 | 11070.0 | 3 |
| SUD4 CHEMBL613711 | IC50 | 4.84 | 4.84 | 14340.0 | 1 |
| BT-549 CHEMBL614072 | IC50 | 4.81 | 4.43 | 15360.0 | 3 |
| A549 CHEMBL392 | IC50 | 4.8 | 4.8 | 15830.0 | 1 |
| SU-DHL-6 CHEMBL4296496 | IC50 | 4.66 | 4.66 | 21950.0 | 1 |
| MV4-11 CHEMBL613835 | IC50 | 4.65 | 4.65 | 22380.0 | 1 |
| HeLa CHEMBL399 | IC50 | 4.56 | 4.56 | 27690.0 | 1 |
| 4T1 CHEMBL612589 | IC50 | 4.53 | 4.53 | 29300.0 | 1 |
| A2780 CHEMBL614004 | IC50 | 4.33 | 4.33 | 47000.0 | 1 |
| MDA-MB-468 CHEMBL614335 | IC50 | 4.33 | 4.33 | 46670.0 | 2 |
| PA-1 CHEMBL614949 | IC50 | 4.33 | 4.33 | 46600.0 | 1 |
| K562 CHEMBL385 | IC50 | 4.23 | 4.23 | 59200.0 | 1 |
| SK-BR-3 CHEMBL613834 | IC50 | 4.17 | 4.17 | 67100.0 | 1 |
| ES-2 CHEMBL5058622 | IC50 | 4.1 | 4.1 | 79000.0 | 1 |
| SK-OV-3 CHEMBL614925 | IC50 | 4.05 | 4.05 | 89800.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 2500.0 | ng.hr.mL-1 | Mus musculus |
| AUC | 4335.0 | ng.hr.mL-1 | Mus musculus |
| AUC | 2710.0 | ng.hr.mL-1 | Mus musculus |
| AUC | 4371.0 | ng.hr.mL-1 | Mus musculus |
| AUC | 2719.0 | ng.hr.mL-1 | Mus musculus |
| CL | 13.0 | mL.min-1.kg-1 | Mus musculus |
| CL | 22.0 | mL.min-1.kg-1 | Mus musculus |
| CL | 103.0 | mL.min-1.g-1 | Homo sapiens |
| CL | 173.82 | mL.min-1.g-1 | Homo sapiens |
| CL | 12.4 | mL.min-1.kg-1 | Mus musculus |
| CL | 1718.2 | mL.min-1.kg-1 | Mus musculus |
| CL | 346.9 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 457.7 | mL.min-1.kg-1 | Canis lupus familiaris |
| CL | 237.2 | mL.min-1.kg-1 | Macaca mulatta |
| CL | 65.7 | mL.min-1.kg-1 | Homo sapiens |
| Cmax | 3399.39 | nM | Mus musculus |
| Cmax | 3516.37 | nM | Mus musculus |
| F | 55.0 | % | Mus musculus |
| F | 20.0 | % | Mus musculus |
| F | 32.0 | % | Mus musculus |
| Fu | 0.014 | - | Mus musculus |
| Ka | 8.093 | 10^6/M/s | Homo sapiens |
| Ka | 8.84 | 10^5/M/s | Homo sapiens |
| Ka | 5.656 | 10^6/Ms | Homo sapiens |
| Ka | 4.49 | 10^5/M/s | Homo sapiens |
| T1/2 | 1.6 | hr | Mus musculus |
| T1/2 | 0.3367 | hr | Homo sapiens |
| T1/2 | 0.1328 | hr | Homo sapiens |
| T1/2 | 0.88 | hr | Mus musculus |
| T1/2 | 0.59 | hr | Mus musculus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine